Safety and efficacy of inhaled insulin (AERx^® iDMS¹) compared with subcutaneous insulin therapy in patients with Type 1 diabetes: 1‐year data from a randomized, parallel group trial

Abstract

The safety and efficacy results in this trial were similar to those reported with other inhaled insulins; however, inhaled insulin using AERx iDMS requires further optimization to reduce nocturnal hypoglycaemia before it has comparable safety and efficacy to s.c. insulin aspart.